The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Empiric Use of Trimethoprim‐Sulfamethoxazole (TMP‐SMX) in the Treatment of Women with Uncomplicated Urinary Tract Infections, in a Geographical Area with a High Prevalence of TMP‐SMX–Resistant Uropathogens
Abstract
This study evaluated whether trimethoprim-sulfamethoxazole (TMP-SMX) is effective for treatment of uncomplicated urinary tract infections (UTIs) due to TMP-SMX-resistant (TMP-SMX-R) pathogens. Healthy nonpregnant premenopausal women with symptomatic lower UTI were assessed for the presence of pyuria and bacteriuria; if either was present, a urine sample was cultured and TMP-SMX was prescribed. Clinical and microbiologic cure was assessed at days 5-9 and 28-42 after cessation of therapy. For 71%, of patients, cultures grew TMP-SMX-susceptible (TMP-SMX-S) microorganisms, and for 29%, cultures grew TMP-SMX-R organisms. Escherichia coli remained the predominant bacteria in both groups of cultures. At visit 2, microbiological cure had been achieved in 86% of the patients in the TMP-SMX-S group and 42% of those in the TMP-SMX-R group. Similar differences were found at visit 3 by clinical evaluation. Treatment with TMP-SMX of uncomplicated UTI caused by TMP-SMX-R microorganisms results in microbiologic and clinical failure. In high-resistance areas, TMP-SMX should not be the empiric drug of choice for uncomplicated UTI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trimethoprim and sulfonamide resistance.
Huovinen, P., Sundström, L., Swedberg, G., & Sköld, O. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.2.279 · Cited by 523
Talan, D. A., Stamm, W. E., Hooton, T. M., Moran, G. J., Burke, T., Iravani, A., Reuning-Scherer, J., & Church, D. A. (2000) · JAMA · doi:10.1001/jama.283.12.1583
Self-citation
Cited by
Gupta, K., Hooton, T. M., Naber, K. G., Wullt, B., Colgan, R., Miller, L. G., Moran, G. J., Nicolle, L. E., Raz, R., Schaeffer, A. J., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq257 · Cited by 3,038
“The most evidence in this regard is available for trimethoprim-sulfame-thoxazole, for which clinical, in vitro, and mathematical modeling studies consistently suggest a 20% resistance prevalence for the threshold at which the agent is no longer recommended for treatment of acute cystitis [20, 21].”
Self-citationSetting and Revising Antibacterial Susceptibility Breakpoints
Turnidge, J., & Paterson, D. L. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00047-06 · Cited by 578
EAU Guidelines for the Management of Urinary and Male Genital Tract Infections1
Naber, K. G., Bergman, B., Bishop, M. C., Bjerklund-Johansen, T. E., Botto, H., Lobel, B., Cruz, F. J., & Selvaggi, F. P. (2001) · European Urology · doi:10.1159/000049840 · Cited by 510
Schito, G. C., Naber, K. G., Botto, H., Palou, J., Mazzei, T., Gualco, L., & Marchese, A. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.04.012 · Cited by 421
Karlowsky, J. A., Kelly, L. J., Thornsberry, C., Jones, M. E., & Sahm, D. F. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2540-2545.2002 · Cited by 367
Uncomplicated Urinary Tract Infection in Adults Including Uncomplicated Pyelonephritis
Nicolle, L. E. (2008) · Urologic Clinics of North America · doi:10.1016/j.ucl.2007.09.004 · Cited by 359
Population-Based Epidemiologic Analysis of Acute Pyelonephritis
Czaja, C. A., Scholes, D., Hooton, T. M., & Stamm, W. E. (2007) · Clinical Infectious Diseases · doi:10.1086/519268 · Cited by 337
Self-citationAcute Uncomplicated Urinary Tract Infection in Women
Fihn, S. D. (2003) · New England Journal of Medicine · doi:10.1056/nejmcp030027 · Cited by 332
Naber, K. G., Schito, G., Botto, H., Palou, J., & Mazzei, T. (2008) · European Urology · doi:10.1016/j.eururo.2008.05.010 · Cited by 316
ZHANEL, G., HISANAGA, T., LAING, N., DECORBY, M., NICHOL, K., WESHNOWESKI, B., JOHNSON, J., NOREDDIN, A., LOW, D., & KARLOWSKY, J. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.02.009 · Cited by 302
Hannan, T. J., Mysorekar, I. U., Hung, C. S., Isaacson-Schmid, M. L., & Hultgren, S. J. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001042 · Cited by 287
Simmering, J. E., Tang, F., Cavanaugh, J. E., Polgreen, L. A., & Polgreen, P. M. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw281 · Cited by 267
Antibacterial activity of propolis and honey against Staphylococcus aureus and Escherichia coli.
(2010) · The University of Malaya Research Repository (University of Malaya) · doi:10.5897/ajmr.9000050 · Cited by 101
Kim, A., Ahn, J. H., Choi, W. S., Park, H. K., Kim, S., Paick, S. H., & Kim, H. G. (2021) · International Neurourology Journal · doi:10.5213/inj.2040472.236 · Cited by 22
Metadata
- Authors
- Raz, R., Chazan, B., Kennes, Y., Colodner, R., Rottensterich, E., Dan, M., Lavi, I., Stamm, W., & the Israeli Urinary Tract Infection Group
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-05
- Volume
- 34
- Issue
- 9
- Pages
- 1165-1169
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2142909774
- Cited by
- 221
- References
- 2
- FWCI
- 10.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.